935 F. Supp. 2d 947
N.D. Cal.2013Background
- Brazil sues Dole for allegedly misbranded food product labels under UCL, FAL, CLRA, seeking damages, restitution, and injunction.
- FAC names seven Dole products with claims that labels like “All Natural,” “fresh,” and nutrient/health claims are unlawful or misleading.
- Defendants moved to dismiss or strike; the court held a hearing on January 24, 2013.
- Court analyzes FDCA preemption, standing, plausibility/particularity, and specific statutory warranty claims asserted.
- Court grants in part and denies in part the motion, dismissing several state-law claims with prejudice or without prejudice, and deferring others for amendment.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| FDCA preemption of state claims | Brazil argues no private right preempts state claims mirrored to FDA rules. | Dole claims preemption bars private actions enforcing federal labeling standards. | Preemption denied; state claims parallel to FDA requirements may proceed. |
| Standing (injury in fact) | Brazil alleges economic injury from misbranding; overpayment and lost purchased goods. | Brazil’s injury is insufficient or speculative under Article III. | Brazil shown concrete, particularized economic injury; standing found. |
| Plausibility and Rule 9(b) particularity | Claims based on FDCA violations allege a unified fraudulent scheme; should survive 12(b)(6). | Claims are implausible and insufficiently particular; 9(b) requires specifics. | UCL/FAL/CLRA claims grounded in fraud dismissed for lack of particularity; remaining claims barred or dismissed as noted. |
| Viability of Song-Beverly, MMWA, and unjust enrichment | Brazil asserts warranty and restitution theories alongside misbranding claims. | Consumables fall outside Song-Beverly; MMWA requirements not met; unjust enrichment not separate action. | Song-Beverly and MMWA claims dismissed with prejudice; unjust enrichment restitution claim dismissed with prejudice. |
| Abstention/primary jurisdiction | FDA should resolve labeling standards in regulation rather than court. | Court should stay or abstain pending FDA resolution. | No abstention or primary jurisdiction dismissal; case proceeds on remaining issues. |
Key Cases Cited
- Pom Wonderful LLC v. Coca-Cola Company, 679 F.3d 1170 (9th Cir. 2012) (FDCA preemption discussion limited; not controlling on state claims)
- In re Farm Raised Salmon Cases, 42 Cal.4th 1077 (Cal. 2008) (state enforcement of federal labeling mirrors preemption analysis)
- Stengel v. Medtronic, 704 F.3d 1224 (9th Cir. 2013) (presumption against preemption in parallel state duties)
- Medtronic, Inc. v. Lohr, 518 U.S. 470 (Supreme Court 1996) (parallel state duties under federal scheme allowed; preemption limited)
- Riegel v. Medtronic, Inc., 552 U.S. 312 (Supreme Court 2008) (MDA preemption where state requirements differ from federal ones)
- Brown v. MCI WorldCom Network Servs., 277 F.3d 1166 (9th Cir. 2002) (primary jurisdiction analysis and court's role when agency has expertise)
- Chacanaca v. The Quaker Oats Co., 752 F. Supp. 2d 1111 (N.D. Cal. 2010) (misbranding labeling cases; consumer deception questions within court's purview)
- Jones v. ConAgra Foods, Inc., 912 F. Supp. 2d 889 (N.D. Cal. 2012) (standing and injury via overpayment for misbranded foods)
- Astiana v. Ben & Jerry's Homemade, Inc., 2011 WL 2111796 (N.D. Cal. 2011) (FDA labeling disputes; relevance to misbranding cases)
